NRG Therapeutics is a series a startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
NRG Therapeutics is a drug discovery company targeting mitochondrial dysfunction to slow or prevent the progression of neurodegenerative diseases.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky